MARKET

XFOR

XFOR

X4 Pharmaceuticals Inc
NASDAQ
3.600
-0.060
-1.64%
After Hours: 3.600 0 0.00% 17:39 12/19 EST
OPEN
3.660
PREV CLOSE
3.660
HIGH
3.794
LOW
3.500
VOLUME
5.17M
TURNOVER
--
52 WEEK HIGH
26.83
52 WEEK LOW
1.350
MARKET CAP
314.77M
P/E (TTM)
-0.3427
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XFOR last week (1208-1212)?
Weekly Report · 5d ago
Weekly Report: what happened at XFOR last week (1201-1205)?
Weekly Report · 12/08 10:08
X4 Pharmaceuticals Is Maintained at Buy by Stifel
Dow Jones · 12/05 17:39
Stifel Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $10
Benzinga · 12/05 17:29
X4 Pharmaceuticals price target raised to $10 from $7.50 at Stifel
TipRanks · 12/05 11:40
X4 Pharmaceuticals: Betting On Mavorixafor For Chronic Neutropenia
Seeking Alpha · 12/01 14:09
Weekly Report: what happened at XFOR last week (1124-1128)?
Weekly Report · 12/01 10:04
Cantor Fitzgerald Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR)
TipRanks · 11/24 13:16
More
About XFOR
X4 Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on discovering and developing novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. Its lead clinical candidate is mavorixafor, a small-molecule selective antagonist of chemokine receptor CXCR4. It has developed a small-molecule, oral antagonists of the chemokine receptor C-X-C receptor type 4 (CXCR4). It has two pre-clinical candidates: X4P-003, a second-generation CXCR4 antagonist designed to have enhanced properties relative to mavorixafor, potentially enabling opportunities in CXCR4-dependent disorders and primary immunodeficiencies, and X4P-002, a CXCR4 antagonist with a distribution profile and a demonstrated ability to cross the blood-brain barrier.

Webull offers X4 Pharmaceuticals Inc stock information, including NASDAQ: XFOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XFOR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XFOR stock methods without spending real money on the virtual paper trading platform.